RNASE4 and benign prostatic hyperplasia: We report that RNASE4 expression is increased progressively in prostate cancer, correlates with aggressiveness of the disease, can accurately distinguish between healthy, BPH, and prostate cancer, and can independently predict biopsy outcome.